Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancerF Crippa, G Bolis, E Seregni, et al.
Gynecologic Oncology|January 16, 1999
Paclitaxel vs epidoxorubicin plus paclitaxel as second-line therapy for platinum-refractory and -resistant ovarian cancerG Bolis, F Parazzini, G Scarfone, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Epidoxorubicin versus no treatment as consolidation therapy in advanced ovarian cancer: results from a phase II studyG Bolis, S Danese, S Tateo, et al.
Gynecologic Oncology|October 1, 1996
Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancerG Bolis, I van Zainten-Przybysz, G Scarfone, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimenG Bolis, G Scarfone, L Luchini, et al.
Cancer|January 1, 1996
Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomyG Bolis, A Villa, P Guarnerio, et al.
Gynecologic Oncology|March 30, 2001
Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancerG Bolis, G Scarfone, G Giardina, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Potentials of cell kinetics in the management of patients with ovarian cancersR Silvestrini, M G Daidone, B Valentinis, et al.
Tumori|April 29, 2000
[Topotecan: prospects for using it in combination therapy for ovarian carcinoma]G Scarfone
Cancer|January 15, 1998
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocolR Silvestrini, M G Daidone, S Veneroni, et al.
Pageof 11